Comparative safety of istradefylline in Parkinson's disease: A systematic review of randomized controlled trials and real-world studies.

Betté S, Qian J, Cummings H, Shimoda H, Shinoda K, Thai A, Batson S, Redhead G, Hodkinson A, Truong D

Open source

DOI
10.1016/j.prdoa.2025.100307
Published
2025
Container
Clinical parkinsonism & related disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.prdoa.2025.100307,
  title = {Comparative safety of istradefylline in Parkinson's disease: A systematic review of randomized controlled trials and real-world studies.},
  author = {Betté S and Qian J and Cummings H and Shimoda H and Shinoda K and Thai A and Batson S and Redhead G and Hodkinson A and Truong D},
  year = {2025},
  journal = {Clinical parkinsonism \& related disorders},
  doi = {10.1016/j.prdoa.2025.100307},
  url = {https://doi.org/10.1016/j.prdoa.2025.100307}
}

RIS

TY  - JOUR
TI  - Comparative safety of istradefylline in Parkinson's disease: A systematic review of randomized controlled trials and real-world studies.
AU  - Betté S
AU  - Qian J
AU  - Cummings H
AU  - Shimoda H
AU  - Shinoda K
AU  - Thai A
AU  - Batson S
AU  - Redhead G
AU  - Hodkinson A
AU  - Truong D
PY  - 2025
JO  - Clinical parkinsonism & related disorders
DO  - 10.1016/j.prdoa.2025.100307
UR  - https://doi.org/10.1016/j.prdoa.2025.100307
ER  - 

APA

S, B., J, Q., H, C., H, S., K, S., A, T., S, B., G, R., A, H., & D, T. (2025). Comparative safety of istradefylline in Parkinson's disease: A systematic review of randomized controlled trials and real-world studies.. Clinical parkinsonism & related disorders. https://doi.org/10.1016/j.prdoa.2025.100307

Source records